Deep Dive
-
National CineMedia Wants a Bigger Audience—Here’s How It’s Getting One
National CineMedia is acquiring Spotlight Cinema Networks to expand into premium boutique theaters, boosting its national share and strengthening its…
Read More » -
Nanox’s Bold $800K Bet: Can VasoHealthcare IT Jumpstart U.S. AI Imaging?
Nanox’s planned acquisition of VasoHealthcare IT signals a strategic push to speed U.S. adoption of its AI imaging tech by…
Read More » -
Genco’s Newcastlemax Buyout: The Quiet Move That Could Supercharge Its Small Cap Story
Genco is adding two modern scrubber-fitted Newcastlemax ships for $145.5M, aiming to boost scale and efficiency as dry bulk supply…
Read More » -
Sickle-Cell Setback Or Acquisition Setup? Agios’ 48% Drop Could Draw Dealmakers
Agios plunged 48% after its Phase III Pyrukynd trial delivered mixed results, missing key pain-crisis and fatigue endpoints. Despite strong…
Read More » -
Priority Technology Turmoil: Shareholder Revolt Explodes Over CEO’s Low-Ball Takeover Bid
Priority Tech faces turmoil as major holder Steamboat blasts the CEO’s go-private bid as too low. With improving results and…
Read More » -
Sprout Social Jumps on M&A Chatter — What the Adobe Rumors Really Mean!
Sprout Social drew attention after takeover rumors linked Adobe to a possible bid. Strong 13% revenue growth, record margins, and…
Read More » -
Voyager Technologies Just Bought Estes—Here’s Why It Could Redefine Missile Defense!
Voyager’s acquisition of Estes Energetics boosts vertical integration in missile tech, aligning with DoD priorities and strengthening supply-chain control, but…
Read More » -
Kaltura Goes All-In on Avatars & AI — Will eSelf Make or Break Them?
Kaltura is making waves after agreeing to buy eSelf.ai for $27M, a move that accelerates its shift from video SaaS…
Read More » -
Alphabet’s Race Toward a $4 Trillion Valuation Signals a New Phase of AI Dominance
Alphabet is approaching a $4 trillion market value after a recent surge that reshaped investor expectations for the future of…
Read More » -
Pacira BioSciences Pops As Activist Investor Calls For Sale — What You Need To Know!
Pacira jumped into M&A chatter after investor DOMA Perpetual urged a full sale, arguing the biotech could fetch $66/share. Activist…
Read More »
